Prof. Dr. Pongrama Ramasoota, Mahidol University, Thailand.
Dr. Pongrama Ramasoota is a distinguished professor and researcher specializing in antibody research and virology at the Centre of Excellence for Antibody Research (CEAR), Mahidol University, Thailand. With a strong academic foundation in veterinary medicine, public health, and microbiology, he has dedicated his career to developing therapeutic and diagnostic monoclonal antibodies against viruses such as Dengue, Rabies, Foot and Mouth Disease, and Influenza. His contributions extend beyond infectious disease research, as he has also explored anti-aging supplements for humans and pets. Recognized with numerous national and international awards, his research has significantly impacted medical biotechnology, earning him a reputation as a leading scientist in his field.
Profile
š Early Academic Pursuits
Pongrama Ramasootaās journey into the world of microbiology and antibody research began with a solid foundation in veterinary medicine. He earned his Doctor of Veterinary Medicine from Kasetsart University, where his fascination with infectious diseases and immunology took root. His academic pursuits led him to Mahidol University, where he obtained a Master of Public Health, further broadening his expertise in disease prevention and control. Driven by a passion for scientific exploration, he pursued a Master of Science and Ph.D. in Microbiology at the prestigious Swedish University of Agricultural Sciences in Uppsala, Sweden. These formative years were instrumental in shaping his career as a leading researcher in antibody development and disease management.
š„ Professional Endeavors
As a distinguished professor at the Centre of Excellence for Antibody Research (CEAR) within the Faculty of Tropical Medicine, Mahidol University, Dr. Ramasoota has dedicated his career to advancing the field of immunotherapy. His research primarily focuses on developing neutralizing monoclonal antibodies to combat viral threats such as Dengue and Rabies. Over the years, he has led groundbreaking projects aimed at creating effective therapeutic and diagnostic solutions. His expertise has also extended beyond academia, as he collaborates with industry leaders to translate research into practical applications that benefit global health.
š¦ Contributions and Research Focus
Dr. Ramasootaās contributions to medical research are vast and impactful. His work on neutralizing human monoclonal antibodies against Dengue and Rabies viruses has paved the way for potential life-saving treatments. His research extends to diagnostic monoclonal antibodies for detecting Foot and Mouth Disease Virus (FMDV) and Influenza, significantly enhancing disease surveillance. Beyond infectious diseases, he has also ventured into anti-aging research, developing natural supplements to promote longevity in both humans and pets. His relentless pursuit of innovation continues to drive advancements in virology, immunotherapy, and biotechnology.
š Accolades and Recognition
Dr. Ramasootaās contributions to science have been recognized with numerous prestigious awards. He was honored as Thailandās Outstanding Researcher in 2020 and named Thailandās Outstanding Veterinarian in 2016. His innovative work earned him multiple Outstanding Research and Invention Awards from the National Research Council of Thailand between 2008 and 2016. He has also received international recognition, including a gold medal from the 2014 Taipei Invention & Techno Mart and awards from the Korea Invention Association and the International Federation of Inventorsā Associations. These accolades underscore his influence as a pioneer in antibody research and biotechnology.
š Impact and Influence
With an H-index of 18 and over 1,038 citations on Scopus, Dr. Ramasootaās research has significantly influenced the scientific community. His findings have been instrumental in shaping new treatment strategies for viral diseases, providing hope for better therapeutic interventions. Collaborating with industry leaders such as Advy Chemical (India) and Thai-Naoka (Thailand), he has helped bridge the gap between research and real-world applications. His contributions to diagnostic tools and monoclonal antibody therapies continue to shape the future of virology and medical biotechnology.
š Legacy and Future Contributions
Beyond his research endeavors, Dr. Ramasoota has authored books that highlight his expertise in environmental management and anti-aging technologies. His book Hallmarks of Aging, Technology and Innovation for Anti-Aging explores groundbreaking advancements in longevity research, demonstrating his commitment to improving human health across various dimensions. As he continues to innovate, his legacy as a leading researcher in antibody development and viral immunotherapy will inspire future generations of scientists. His ongoing efforts to combat infectious diseases and promote healthier aging promise a lasting impact on global health and biotechnology.
Publication
-
Title: Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs
Authors: A. Chorpunkul, U. Boonyuen, K. Limkittikul, P. Lekcharoensuk, P. Ramasoota
Year: 2024
-
Title: Characterization of Vibrio parahaemolyticus isolated from clinical specimens and oysters in Thailand
Authors: N. Tewawong, S. Kowaboot, S. Kengkarn, P. Ramasoota, O. Suthienkul
Year: 2024
-
Title: Nicotiana benthamiana as a potential source for producing anti-dengue virus D54 neutralizing therapeutic antibody
Authors: S. Krittanai, K. Rattanapisit, C.J.I. Bulaon, R. Strasser, W. Phoolcharoen
Year: 2024
-
Title: Associations of effort-reward imbalance at work and quality of life among workers after stroke: a one-year longitudinal study in Thailand
Authors: S. Naknoi, J. Li, P. Ramasoota, N. Soonthornworasiri, O. Kaewboonchoo
Year: 2023
-
Title: Potential Protective Effect of Dengue NS1 Human Monoclonal Antibodies against Dengue and Zika Virus Infections
Authors: R. Sootichote, W. Puangmanee, S. Benjathummarak, P. Ramasoota, P. Pitaksajjakul
Year: 2023
-
Title: A replication competent luciferase-secreting DENV2 reporter for sero-epidemiological surveillance of neutralizing and enhancing antibodies
Authors: K. Saipin, B.K. Thaisomboonsuk, B. Siridechadilok, N. Sittisombut, J. Junjhon
Year: 2022
-
Title: Spread of a Novel Indian Ocean Lineage Carrying E1āK211E/E2āV264A of Chikungunya Virus East/Central/South African Genotype across the Indian Subcontinent, Southeast Asia, and Eastern Africa
Authors: J. Phadungsombat, H.A. Imad, E.E. Nakayama, W. Piyaphanee, T. Shioda
Year: 2022
šÆ Conclusion
Dr. Ramasootaās work has not only advanced scientific knowledge but also contributed to real-world solutions in disease treatment and diagnostics. His collaborations with industries and commitment to innovation ensure that his research continues to benefit global health. As he continues to push the boundaries of antibody research and anti-aging science, his legacy will inspire future generations of scientists, leaving a lasting impact on virology, immunotherapy, and biotechnology.